TY - JOUR
T1 - Antipsychotic polypharmacy in schizophrenia patients in China and its association with treatment satisfaction and quality of life: findings of the third national survey on use of psychotropic medications in China
AU - Li, Q.
AU - Xiang, Y.T.
AU - Su, Y.A.
AU - Shu, L.
AU - Yu, X.
AU - Chiu, H.F.K.
AU - Correll, C.U.
AU - Ungvari, Gabor
AU - Lai, K.Y.C.
AU - Ma, C.
AU - Wang, G.H.
AU - Bai, P.S.
AU - Li, T.
AU - Sun, L.Z.
AU - Shi, J.G.
AU - Chen, X.S.
AU - Mei, Q.Y.
AU - Li, K.Q.
AU - Si, T.M.
PY - 2015
Y1 - 2015
N2 - © The Royal Australian and New Zealand College of Psychiatrists 2014. Objective: This study examined the use, demographic and clinical correlates of antipsychotic polypharmacy (APP) and its associations with treatment satisfaction and quality of life (QOL) in schizophrenia patients in China. Method: A total of 4239 patients in 45 nationwide Chinese psychiatric hospitals/centers were interviewed in 2012 in the third cross-sectional study, with the first two having been conducted in 2002 and 2006. Patients' socio-demographic and clinical characteristics, including psychopathology, side effects, satisfaction with treatment and QOL, were recorded using a standardized protocol and data collection procedure. Results: The proportion of APP prescriptions in 2012 was 34.2%, which was significantly higher than the frequency of APP in 2002 (26.1%) and 2006 (26.4%) (p2=0.31, p
AB - © The Royal Australian and New Zealand College of Psychiatrists 2014. Objective: This study examined the use, demographic and clinical correlates of antipsychotic polypharmacy (APP) and its associations with treatment satisfaction and quality of life (QOL) in schizophrenia patients in China. Method: A total of 4239 patients in 45 nationwide Chinese psychiatric hospitals/centers were interviewed in 2012 in the third cross-sectional study, with the first two having been conducted in 2002 and 2006. Patients' socio-demographic and clinical characteristics, including psychopathology, side effects, satisfaction with treatment and QOL, were recorded using a standardized protocol and data collection procedure. Results: The proportion of APP prescriptions in 2012 was 34.2%, which was significantly higher than the frequency of APP in 2002 (26.1%) and 2006 (26.4%) (p2=0.31, p
U2 - 10.1177/0004867414536931
DO - 10.1177/0004867414536931
M3 - Article
SN - 0004-8674
VL - 49
SP - 129
EP - 136
JO - Australian & New Zealand Journal of Psychiatry
JF - Australian & New Zealand Journal of Psychiatry
IS - 2
ER -